Cargando…

WDR43 is a potential diagnostic biomarker and therapeutic target for osteoarthritis complicated with Parkinson’s disease

Osteoarthritis (OA) and Parkinson’s disease (PD) are on the rise and greatly impact the quality of individuals’ lives. Although accumulating evidence indicates a relationship between OA and PD, the particular interactions connecting the two diseases have not been thoroughly examined. Therefore, this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heng, Hongquan, Liu, Jie, Hu, Mingwei, Li, Dazhuang, Su, Wenxing, Li, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677099/ https://www.ncbi.nlm.nih.gov/pubmed/36419937 http://dx.doi.org/10.3389/fncel.2022.1013745

Ejemplares similares

Cromolyn prevents cerebral vasospasm and dementia by targeting WDR43
por: Wang, Xingqiao, et al.
Publicado: (2023)

MicroRNAs in Huntington’s Disease: Diagnostic Biomarkers or Therapeutic Agents?
por: Dong, Xiaoyu, et al.
Publicado: (2021)

Exploration of comorbidity mechanisms and potential therapeutic targets of rheumatoid arthritis and pigmented villonodular synovitis using machine learning and bioinformatics analysis
por: Heng, Hongquan, et al.
Publicado: (2023)

Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
por: Magdy, Alshimaa, et al.
Publicado: (2022)

Editorial: Neuro-glia-immune communication: novel biomarkers and therapeutic targets
por: Gubert, Fernanda, et al.
Publicado: (2023)

Corrigendum: TDP-43 and NEAT long non-coding RNA: Roles in neurodegenerative disease
por: Sekar, Durairaj, et al.
Publicado: (2022)

Inference of Diagnostic Markers and Therapeutic Targets From CSF Proteomics for the Treatment of Hydrocephalus
por: Horowitz, Arie, et al.
Publicado: (2020)

A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
por: Saha, Sarmistha, et al.
Publicado: (2022)

Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis
por: Paez-Colasante, Ximena, et al.
Publicado: (2020)

The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS
por: Dafinca, Ruxandra, et al.
Publicado: (2021)

Synaptic remodeling follows upper motor neuron hyperexcitability in a rodent model of TDP-43
por: Dyer, Marcus S., et al.
Publicado: (2023)

Cytoplasmic Expression of the ALS/FTD-Related Protein TDP-43 Decreases Global Translation Both in vitro and in vivo
por: Charif, Santiago E., et al.
Publicado: (2020)

Neuronal models of TDP-43 proteinopathy display reduced axonal translation, increased oxidative stress, and defective exocytosis
por: Pisciottani, Alessandra, et al.
Publicado: (2023)

The Mechanism and Function of Glia in Parkinson's Disease
por: Zhang, Xinguo, et al.
Publicado: (2022)

Mitoautophagy: A Unique Self-Destructive Path Mitochondria of Upper Motor Neurons With TDP-43 Pathology Take, Very Early in ALS
por: Gautam, Mukesh, et al.
Publicado: (2019)

Live-Cell Assays for Cell Stress Responses Reveal New Patterns of Cell Signaling Caused by Mutations in Rhodopsin, α-Synuclein and TDP-43
por: Harlen, Kevin M., et al.
Publicado: (2019)

Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease
por: Roser, Anna Elisa, et al.
Publicado: (2018)

Tissue Specific Roles for the Ribosome Biogenesis Factor Wdr43 in Zebrafish Development
por: Zhao, Chengtian, et al.
Publicado: (2014)

MiR-30c-5p/ATG5 Axis Regulates the Progression of Parkinson’s Disease
por: Zhang, Li, et al.
Publicado: (2021)

Novel diagnostic biomarkers related to immune infiltration in Parkinson’s disease by bioinformatics analysis
por: Zhang, Pengfei, et al.
Publicado: (2023)

Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism
por: Faynveitz, Anna, et al.
Publicado: (2019)

Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson’s Disease
por: Han, Deqiang, et al.
Publicado: (2020)

Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease
por: Gcwensa, Nolwazi Z., et al.
Publicado: (2021)

Commentary: Roles of the Cannabinoid System in the Basal Ganglia in Parkinson's Disease
por: Oikonomou, Panteleimon, et al.
Publicado: (2022)

Local Delivery of Therapeutics to the Inner Ear: The State of the Science
por: Anderson, Caroline R., et al.
Publicado: (2019)

Spinal Muscular Atrophy Type IIIb Complicated by Moyamoya Syndrome: A Case Report and Literature Review
por: Li, Jing, et al.
Publicado: (2022)

Chemically Induced Models of Parkinson’s Disease: History and Perspectives for the Involvement of Ferroptosis
por: Wen, Shuheng, et al.
Publicado: (2020)

Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson’s Disease Risk
por: Booms, Alix, et al.
Publicado: (2021)

HMGA1 Induction of miR-103/107 Forms a Negative Feedback Loop to Regulate Autophagy in MPTP Model of Parkinson’s Disease
por: Li, Gehui, et al.
Publicado: (2021)

Therapeutic Development for CGG Repeat Expansion-Associated Neurodegeneration
por: Xu, Keqin, et al.
Publicado: (2021)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
por: Zhang, Guimei, et al.
Publicado: (2021)

Focused Ultrasound Promotes the Delivery of Gastrodin and Enhances the Protective Effect on Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease
por: Wang, Yuhong, et al.
Publicado: (2022)

NLRP3-Dependent Pyroptosis: A Candidate Therapeutic Target for Depression
por: Wan, Teng, et al.
Publicado: (2022)

Therapeutic targets and signaling mechanisms of dasatinib activity against radiation skin ulcer
por: Su, Wenxing, et al.
Publicado: (2022)

Editorial: Advances in CNS Repair, Regeneration, and Neuroplasticity: From Basic Mechanisms to Therapeutic Strategies
por: Li, Shuxin
Publicado: (2022)

Competing endogenous RNA (ceRNA) networks in Parkinson's disease: A systematic review
por: Asadi, Mohammad Reza, et al.
Publicado: (2023)

Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease
por: Yang, Yimin, et al.
Publicado: (2021)

From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
por: Mancini, Andrea, et al.
Publicado: (2020)

Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
por: Simmnacher, Katrin, et al.
Publicado: (2020)

Septic encephalopathy in the elderly – biomarkers of potential clinical utility
por: Schütze, Sandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_34gvpki3vc3jv5qeeae7b34ioj